Philips announced a 4% increase in comparable sales for Q2 2024, driven by growth across all segments and a notable 13% contribution from emerging markets. The company achieved €132 million in savings during Q2 and €258 million in the first half of the year, which helped improve adjusted EBITA margins significantly. Additionally, Philips saw a 5% rise in rolling 12-month order intake and generated free cash flow of €222 million, maintaining a manageable leverage ratio of about 1.8x EBITDA. These strong financial results support the analyst's Buy rating and suggest attractive valuation upside for investors.
Royal Philips has announced new collaborations with several companies to expand its open patient monitoring ecosystem. These partnerships integrate wearable and out-of-hospital monitoring technologies into Philips' system, enabling continuous patient...
Philips Avent introduced the Share the Care Connector, an SMS-based tool designed to help new mothers easily coordinate support from friends and family during the postpartum period. The tool sends personalized prompts to a mom's support network, enco...
